NCT06388070View on ClinicalTrials.gov

To Evaluate the Efficacy and Safety of HUC3-053 in Patients with Dry Eye Syndrome

PHASE3RecruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Dry Eye Syndromes
Interventions
DRUG

HUC3-053

drops in each eye five to six times a day for 12 weeks

DRUG

Hyalein Mini Drops

drops in each eye five to six times a day for 12 weeks.

Trial Locations (1)

03181

RECRUITING

Gangbuk Samsung Hospital, Seoul

All Listed Sponsors
lead

Huons Co., Ltd.

INDUSTRY